Last reviewed · How we verify

Prilocaine 0.5%

Bozyaka Training and Research Hospital · FDA-approved active Small molecule

Prilocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

Prilocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses. Used for Local anesthesia for infiltration, nerve blocks, and topical application, Dental anesthesia, Minor surgical procedures.

At a glance

Generic namePrilocaine 0.5%
Also known asCitanest
SponsorBozyaka Training and Research Hospital
Drug classLocal anesthetic (amide)
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia
PhaseFDA-approved

Mechanism of action

Prilocaine works by reversibly inhibiting sodium influx through voltage-gated sodium channels in nerve fibers, which stabilizes the neuronal membrane and raises the threshold for electrical excitability. This prevents the generation and propagation of action potentials, resulting in local anesthesia in the area of administration. It is an amide-type local anesthetic with intermediate potency and duration of action.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: